. 2016 Jun 24;25(6):510–516. doi: 10.1159/000447948

Table 2.

Laboratory data of the study groups

	RA (n = 91)	SLE (n = 51)	SSc (n = 39)	BD (n = 53)	HC (n = 55)	p values
ESR, mm/h	29 (3– 105)^**	38 (4–116)^***	21 (2– 98)	18 (3–96)^†,^‡‡‡	18 (3–52)	<0.001^a
CRP, mg/dl	1.10 (0.01–35.00)^**	0.10 (0.01–5.80)^**,^††	0.40 (0.01–3.50)^**,^††	0.40 (0.01–10.00)	0.30 (0.01–1.20)	<0.001^a
WBC, 10³/μl	7.6 ± 2.5^*	5.7 ± 2.5^†††	7.5 ± 2.5^‡‡	7.1 ± 2.2^‡	6.5 ± 1.5	<0.001^b
Neutrophils, 10³/μl	5.1 ± 2.1^***	3.9 ± 1.9^††	4.9 ± 2.1^**	4.2 ± 1.6	3.7 ± 1.1	<0.001^b
Lymphocytes, 10³/μl	1.8 ± 0.6^‡‡‡	1.2 ± 0.6^***	1.8 ± 1^‡‡	2.1 ± 0.9^‡‡‡	2.1 ± 0.6	<0.001^b
PLT, 10³/μl	303.3 ± 94.7	251.5 ± 93.4^††	293.1 ± 95.5	260.7 ± 75^†	272.5 ± 75.2	0.05^b
Hb, g/dl	12.4 ± 1.7^**	11.5 ± 1.9^***,^†	12.4 ± 1.7^**	13.4 ± 1.5^††,^‡‡‡	13.5 ± 1.2	<0.001^b
MPV, fl	8.7 ± 1.6	9.5 ± 1.7^†	8.8 ± 1.1	9.2 ± 2.2	8.8 ± 1.5	0.510^b
MPR (10⁵/μl), fl	2.9 (0.2–11.7)	3.5 (1.9–13.7)^††	3.2 (0.2–8.4)	3.6 (1.5–9.3)	3.1 (1.5–14.9)	0.023^a
PLR	177.8 (65.6–775.0)^‡‡	232.1 (56.8–1050.0)^***	155.7 (34.2–876.7)	129.3 (55.6–276.0)^‡‡‡	133.2 (39.5–296.7)	<0.001^a
NLR	2.5 (0.8–16.7)^*	2.9 (0.8–17.4)^***	2.7 (0.6–19.6)^**	2.2 (0.4–5.0)^‡‡	1.7 (0.9–5.4)	<0.001^a

When compared to the HC group:

p < 0.05

^**

p < 0.01

^***

p < 0.001.

When compared to the RA group

^†

p < 0.05

^††

p < 0.01

^†††

p < 0.001.

When compared to the SLE group

^‡

p < 0.05

^‡‡

p < 0.01

^‡‡‡

p < 0.001.

Kruskal-Wallis p values.

ANOVA p values.

WBC = White blood cell; PLT = platelets; Hb = hemoglobin.